東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Examination of the Role of Envelope ...

Registre, Ludy.

Linked to FindBook

Google Book

Amazon

博客來

Examination of the Role of Envelope Directed Antibodies on Co-receptor Usage in HIV-1B Infection.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Examination of the Role of Envelope Directed Antibodies on Co-receptor Usage in HIV-1B Infection./
Author:	Registre, Ludy.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
Description:	167 p.
Notes:	Source: Dissertations Abstracts International, Volume: 79-12, Section: B.
Contained By:	Dissertations Abstracts International79-12B.
Subject:	Microbiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10751672
ISBN:	9780438066861

Examination of the Role of Envelope Directed Antibodies on Co-receptor Usage in HIV-1B Infection.
Registre, Ludy.

Examination of the Role of Envelope Directed Antibodies on Co-receptor Usage in HIV-1B Infection. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 167 p.

Source: Dissertations Abstracts International, Volume: 79-12, Section: B.

Thesis (Ph.D.)--Boston University, 2018.

This item is not available from ProQuest Dissertations & Theses.

HIV-1 primarily utilizes the CCR5 receptor as a co-receptor, but over time, viruses can evolve to use the CXCR4 protein. Changes in the viral envelope V3 loop mediate this switch. The emergence of CXCR4-utilizing viruses has been presumed to occur as a consequence of decreased humoral immunity. We show that exclusively CXCR4-using (X4) viruses contain a 2 to 3 amino acid insertion in the V3 loop. Structural modeling revealed that this insertion caused a protrusion in the V3 loop, which impacts CCR5 receptor interaction. These genotypic and structural motifs affected neutralization susceptibility because X4, as compared to co-circulating CCR5-utilizing (R5) viruses, were less neutralization sensitive to autologous contemporaneous and heterologous plasma. Individuals with co-circulating X4 and R5, as compared to those with only R5, viruses had similar neutralization breadth and potency indicating that the emergence of X4 viruses is not associated with decreased humoral immunity. These results suggest that X4 viruses are neutralization escape variants and arise due to humoral selective pressure. This work has implications for future antibody-based therapeutics. Along with providing a framework for developing an HIV-1 vaccine, broadly neutralizing antibodies (bnAbs) are also being investigated as a potential therapeutic. BnAbs target a limited number of conserved HIV-1 envelope structures, including glycans in and around the V1/V2 and V3 domains. Along with the V3 loop, changes in V1/V2 are also known to impact co-receptor usage. We show that viruses that exclusively use the CXCR4 co-receptor, as compared to variants that only utilize CCR5, were less neutralization sensitive to V1/V2 and V3 directed bnAbs. In contrast, R5 and X4 viruses did not demonstrate neutralization differences to bnAbs that target non-V1/V2 and V3 envelope regions, such as the CD4 binding site and the membrane proximal external region. Structural modeling revealed that the predicted orientation of the V1/V2 loop among diverse HIV-1 variants predicts susceptibility to V3 loop directed bnAbs. In aggregate, our results suggest that viruses with different co-receptor usage have differing bnAb susceptibility. Furthermore, structural modeling may be used as a tool to predict neutralization susceptibility to bnAbs against regions associated with co-receptor usage.

ISBN: 9780438066861Subjects--Topical Terms:

536250
Microbiology.
Subjects--Index Terms:

Broadly neutralizing antibodies

Examination of the Role of Envelope Directed Antibodies on Co-receptor Usage in HIV-1B Infection.
LDR:03798nmm a2200433 4500 001 2272183
005 20201105105954.5
008 220629s2018 ||||||||||||||||| ||eng d
020 $a 9780438066861
035 $a (MiAaPQ)AAI10751672
035 $a (MiAaPQ)bu:13566
035 $a AAI10751672
040 $a MiAaPQ $c MiAaPQ
100 1 $a Registre, Ludy. $3 3549612
245 1 0 $a Examination of the Role of Envelope Directed Antibodies on Co-receptor Usage in HIV-1B Infection.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 167 p.
500 $a Source: Dissertations Abstracts International, Volume: 79-12, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Sagar, Manish.
502 $a Thesis (Ph.D.)--Boston University, 2018.
506 $a This item is not available from ProQuest Dissertations & Theses.
506 $a This item must not be added to any third party search indexes.
506 $a This item must not be sold to any third party vendors.
520 $a HIV-1 primarily utilizes the CCR5 receptor as a co-receptor, but over time, viruses can evolve to use the CXCR4 protein. Changes in the viral envelope V3 loop mediate this switch. The emergence of CXCR4-utilizing viruses has been presumed to occur as a consequence of decreased humoral immunity. We show that exclusively CXCR4-using (X4) viruses contain a 2 to 3 amino acid insertion in the V3 loop. Structural modeling revealed that this insertion caused a protrusion in the V3 loop, which impacts CCR5 receptor interaction. These genotypic and structural motifs affected neutralization susceptibility because X4, as compared to co-circulating CCR5-utilizing (R5) viruses, were less neutralization sensitive to autologous contemporaneous and heterologous plasma. Individuals with co-circulating X4 and R5, as compared to those with only R5, viruses had similar neutralization breadth and potency indicating that the emergence of X4 viruses is not associated with decreased humoral immunity. These results suggest that X4 viruses are neutralization escape variants and arise due to humoral selective pressure. This work has implications for future antibody-based therapeutics. Along with providing a framework for developing an HIV-1 vaccine, broadly neutralizing antibodies (bnAbs) are also being investigated as a potential therapeutic. BnAbs target a limited number of conserved HIV-1 envelope structures, including glycans in and around the V1/V2 and V3 domains. Along with the V3 loop, changes in V1/V2 are also known to impact co-receptor usage. We show that viruses that exclusively use the CXCR4 co-receptor, as compared to variants that only utilize CCR5, were less neutralization sensitive to V1/V2 and V3 directed bnAbs. In contrast, R5 and X4 viruses did not demonstrate neutralization differences to bnAbs that target non-V1/V2 and V3 envelope regions, such as the CD4 binding site and the membrane proximal external region. Structural modeling revealed that the predicted orientation of the V1/V2 loop among diverse HIV-1 variants predicts susceptibility to V3 loop directed bnAbs. In aggregate, our results suggest that viruses with different co-receptor usage have differing bnAb susceptibility. Furthermore, structural modeling may be used as a tool to predict neutralization susceptibility to bnAbs against regions associated with co-receptor usage.
590 $a School code: 0017.
650 4 $a Microbiology. $3 536250
650 4 $a Virology. $3 642304
650 4 $a Immunology. $3 611031
653 $a Broadly neutralizing antibodies
653 $a CCR5
653 $a CXCR4
653 $a Co-receptor
653 $a HIV
653 $a Neutralization
690 $a 0410
690 $a 0720
690 $a 0982
710 2 $a Boston University. $b Microbiology GMS. $3 3183043
773 0 $t Dissertations Abstracts International $g 79-12B.
790 $a 0017
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10751672